PRHSX is a growth-oriented health sciences fund predominantly investing in larger US companies involved in health care, medicine, and life sciences, including pharmaceuticals, health services, medical devices, and biotech. It emphasizes companies with innovative treatments and cost-effective business models. While focused on growth, it may adopt a value approach when valuations are high. The fund may also allocate investments internationally and in recently public or private firms.